Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Measuring evoked responses in multiple sclerosis.

G Comi1, L Leocani, S Medaglini

  • 1Department of Clinical Neurophysiology, MS Centre, University of Milan, Scientific Institute H San Raffaele, Milan, Italy.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|September 1, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitoxantrone prior to interferon beta-1b in aggressive relapsing multiple sclerosis: a 3-year randomised trial.

Journal of neurology, neurosurgery, and psychiatry·2011
Same author

Voxelwise assessment of the regional distribution of damage in the brains of patients with multiple sclerosis and fatigue.

AJNR. American journal of neuroradiology·2011
Same author

Thalamic damage predicts the evolution of primary-progressive multiple sclerosis at 5 years.

AJNR. American journal of neuroradiology·2011
Same author

Cortical lesions in children with multiple sclerosis.

Neurology·2011
Same author

Sensorimotor functional connectivity changes in amyotrophic lateral sclerosis.

Cerebral cortex (New York, N.Y. : 1991)·2011
Same author

A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis.

European journal of neurology·2011
Same journal

Impact of multiple sclerosis disease-modifying therapies on chronic lesion tissue expansion.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Tobacco smoking disrupts bile acid and tryptophan metabolism in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Missed radiologic disease activity by conventional side-by-side MRI comparison is associated with future disease activity in multiple sclerosis: Adopting semiautomated coregistration-fusion into clinical practice.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Longitudinal magnetic resonance spectroscopy study of metabolite changes over 2 years in relapsing and primary progressive multiple sclerosis treated with ocrelizumab.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Racial identity, marginalization, and depression in pediatric-onset multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Disability and race in MS: Does socioeconomic disadvantage play a role?

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
See all related articles

Evoked potentials (EPs) help assess neurological damage in Multiple Sclerosis (MS) by reflecting global pathway impairment, correlating with disability. Despite MRI

Area of Science:

  • Neuroscience
  • Clinical Neurology
  • Medical Imaging

Background:

  • Evoked potentials (EPs) are established tools for evaluating sensory and motor pathway involvement in Multiple Sclerosis (MS).
  • EPs can detect subclinical central nervous system damage, particularly in early MS phases with vague symptoms.
  • The clinical utility of EPs has decreased with the rise of Magnetic Resonance Imaging (MRI).

Purpose of the Study:

  • To re-evaluate the distinct diagnostic and monitoring value of EPs in Multiple Sclerosis (MS) compared to MRI.
  • To highlight the complementary information provided by EPs and MRI in MS assessment.
  • To emphasize the correlation between EP changes and clinical disability in MS.

Main Methods:

  • Review of transversal and longitudinal studies comparing Evoked Potentials (EPs) and Magnetic Resonance Imaging (MRI) in Multiple Sclerosis (MS).

Related Experiment Videos

  • Analysis of the relationship between EP abnormalities, MRI lesion burden, and clinical disability.
  • Consideration of technical factors and subclinical disease activity influencing EP modifications.

    • Main Results:

    • EP abnormalities reflect global pathway damage and correlate significantly with clinical findings and disability in MS.
    • MRI is more sensitive in detecting disease activity, but many MRI lesions are asymptomatic.
    • EP changes are more closely linked to MS-related disability than MRI lesion burden.

    Conclusions:

    • EPs offer unique insights into functional neurological deficits in MS, complementing MRI's structural information.
    • Reproducible EP parameters are crucial for monitoring MS progression and treatment efficacy.
    • The distinct information from EPs justifies their continued role in MS management alongside MRI.